EnginZyme Produces Key mRNA Vaccine Ingredient Using Biocatalysis
EnginZyme recently announced that they have patented the process of producing pseudouridine, which is a key ingredient in mRNA COVID-19 vaccines. Their cell-free biomanufacturing technology uses the power of enzymes to create sustainable products and processes for a variety of industries. The manufacturing can take place at an industrial scale using biocatalysis in a sustainable, low-waste, with the patented process carried out in a cGMP Facility.
Congratulations to the team on reaching this significant milestone!